ATE172983T1 - Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik - Google Patents

Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Info

Publication number
ATE172983T1
ATE172983T1 AT92900187T AT92900187T ATE172983T1 AT E172983 T1 ATE172983 T1 AT E172983T1 AT 92900187 T AT92900187 T AT 92900187T AT 92900187 T AT92900187 T AT 92900187T AT E172983 T1 ATE172983 T1 AT E172983T1
Authority
AT
Austria
Prior art keywords
peptide
env
protein
peptide fragments
fiv
Prior art date
Application number
AT92900187T
Other languages
German (de)
English (en)
Inventor
Alexandre Avrameas
Jean Gerard Guillet
Anne Moraillon
Arthur Donny Strosberg
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE172983T1 publication Critical patent/ATE172983T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92900187T 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik ATE172983T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014519A FR2669338A1 (fr) 1990-11-21 1990-11-21 Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.

Publications (1)

Publication Number Publication Date
ATE172983T1 true ATE172983T1 (de) 1998-11-15

Family

ID=9402430

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900187T ATE172983T1 (de) 1990-11-21 1991-11-20 Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik

Country Status (5)

Country Link
EP (1) EP0564477B1 (enExample)
AT (1) ATE172983T1 (enExample)
DE (1) DE69130457T2 (enExample)
FR (1) FR2669338A1 (enExample)
WO (1) WO1992009632A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591572A (en) * 1991-06-14 1997-01-07 St. Vincents Institute Of Medical Research Limited Detection of mammalian immunodeficiency viruses
FR2692270A1 (fr) * 1992-06-16 1993-12-17 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
FR2692269B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Peptides immunogènes et/ou neutralisants de vif de souche WO et leurs applications au diagnostic et à la prévention de l'immunodéficience féline.
FR2692279B1 (fr) * 1992-06-16 1995-05-19 Centre Nat Rech Scient Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
GB9215232D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
FR2769916B1 (fr) * 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
WO2005026733A1 (en) 2003-09-11 2005-03-24 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1709447B1 (en) * 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
AU2005215629B2 (en) * 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (en) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (en) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219725A (en) * 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
EP0471752A4 (en) * 1989-05-08 1992-09-02 Idexx Corp. Polypeptides of feline t-cell lymphotropic lentivirus

Also Published As

Publication number Publication date
WO1992009632A1 (fr) 1992-06-11
EP0564477B1 (fr) 1998-11-04
EP0564477A1 (fr) 1993-10-13
FR2669338B1 (enExample) 1995-03-03
DE69130457T2 (de) 1999-05-27
FR2669338A1 (fr) 1992-05-22
DE69130457D1 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
ATE172983T1 (de) Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
Bertholdt et al. Carbohydrate and other epitopes of contact site A glycoprotein of Dictyostelium discoideum as characterized by monoclonal antibodies
EP1475442A3 (en) Polypeptides of feline T-cell lymphotropic lentivirus
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
DE69635740D1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
TR199901696T2 (xx) Monoklonal veya poliklonal antikorlara ili�kin sabit liyofillenmi� farmakolojik terkipler.
DE68928834D1 (de) Monoklonale antikörper gegen katzen-t-lymphotropes lentivirus
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
NO881151L (no) Syntetisk hiv-1-antigen.
DE69114339T2 (de) Verfahren zur Identifizierung oder Bestimmung von Proteinen und Verwendungen dazu.
ATE206620T1 (de) Menschliche, monoklonale antikörper gegen das transmembrane glycoprotein (gp41) des hiv-1, und verwandte peptide
DE69019190D1 (de) Pankreatische Isletzellen-Antigene, erhalten durch molekulare Klonierung.
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
DK0414178T3 (da) Ikke-humane primat-CD4-polypeptider og humane CD4-molekyler, som kan glycosyleres
DE69033080D1 (de) Zuwachsfaktorrezeptorgen deriviert von platten des typs oc
ATE180512T1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
EP0725081A4 (en) MONOCLONAL ANTIBODY AGAINST MxA OF HUMAN Mx PROTEIN
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
FI904087A7 (fi) Monoklonaalisia vasta-aineita aktivoituja ras-proteiineja vastaan, joi lla on aminohappomutaatioita proteiinin kohdassa 13
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
DK0426314T3 (da) HIV-relaterede peptider
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ATE317851T1 (de) Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie
ATE140233T1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide